Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal cell wall and membrane anionic surface components represent a collective group of negatively charged molecules, including phosphomannans, acidic phospholipids like phosphatidylserine and phosphatidylinositol, and sialic acids, which are essential for structural integrity and environmental adaptation (Gow et al., 2017; Lacerda et al., 2014). These components create a net negative surface charge that is a hallmark of many fungal species, distinguishing them from the relatively neutral outer membranes of host mammalian cells (Bondaryk et al., 2017). This electrostatic profile is a primary target for cationic antimicrobial peptides (CAMPs), such as Histatin 5, LL-37, and synthetic derivatives like Pexiganan, which bind to these anionic sites (Mahlapuu et al., 2016). The interaction typically leads to membrane permeabilization, pore formation, and the leakage of vital intracellular ions and molecules, ultimately resulting in cell death. Beyond structural roles, these anionic components are involved in cell-cell adhesion and the regulation of ion homeostasis, making them critical factors in the pathogenesis of infections such as candidiasis and aspergillosis (Pathak et al., 2022). Targeting these surface features provides a mechanism for selective toxicity, although challenges such as peptide stability and potential hemolytic activity remain significant considerations in drug development.
Electrostatic binding to negatively charged surface components leading to membrane permeabilization and cell lysis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cell wall and membrane anionic surface components.